Alm. Brand A/S
30.6.2026 14:00:00 CEST | Globenewswire | Press release
Alm. Brand A/S – Weekly report on share buybacks
Alm. Brand A/S – Weekly report on share buybacks
Transactions during 23 June 2026 – 29 June 2026
On 7 May 2026, Alm. Brand A/S announced a share buy-back program of up to DKK 593 million, as described in company announcement no. 23/2026.
The program is carried out in accordance with the Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buy-back program 23 June – 29 June 2026:
| Number of shares bought | Average purchase price | Amount (DKK) | |
| Accumulated, last announcement 23 June 2026 24 June 2026 25 June 2026 26 June 2026 29 June 2026 | 3,856,030 180,000 115,374 17,626 179,000 216,674 | 15.25 15.58 15.64 16.01 16.11 16.13 | 58,792,930 2,803,752 1,804,530 282,120 2,883,296 3,494,995 |
| Total, 23 June – 29 June 2026 | 708,674 | 15.90 | 11,268,693 |
| Accumulated under the program | 4,564,704 | 15.35 | 70,061,623 |
With the transactions stated above Alm. Brand A/S holds a total of 38,235,673 own shares, corresponding to 2.72% of the total number of outstanding shares (after the capital reduction by cancellation of treasury shares as per company announcement no. 33/2026)
Contact
Please direct any questions regarding this announcement to:
Investors and equity analysts:
VP, Head of Investor Relations & ESG
Mads Thinggaard
Mobile no, +45 2025 5469
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Nelipak Healthcare Packaging30.6.2026 15:00:00 CEST | Press release
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
Kyowa Kirin30.6.2026 14:30:00 CEST | Press release
New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
Arcturus30.6.2026 14:30:00 CEST | Press release
Arcturus Emerges from Stealth with $8M in Seed Funding to ‘Rewire the World’ with Metals Infused with Carbon Nanomaterials
eQ Oyj30.6.2026 14:30:00 CEST | Press release
eQ Real Estate Funds Completed Refinancings of EUR 915 Million
BellaSeno Pty Ltd30.6.2026 14:27:00 CEST | Press release
BellaSeno’s regenerative scaffolds signal new era for breast surgery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom